Recruiting
Phase 3

Inotuzumab Ozogamicin & Chemotherapy

Sponsor:

Children's Oncology Group

Code:

NCT03959085

Conditions

B Acute Lymphoblastic Leukemia

B Lymphoblastic Lymphoma

Central Nervous System Leukemia

Mixed Phenotype Acute Leukemia

Testicular Leukemia

Eligibility Criteria

Sex: All

Age: 1 - 25

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Bone Marrow Aspiration

Bone Marrow Biopsy

Bone Scan

Calaspargase Pegol

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-08-25. This information was provided to ClinicalTrials.gov by Children's Oncology Group on 2025-05-23.